Acasti Pharma reported $0 in Interest Expense on Debt for its fiscal quarter ending in December of 2024.


Interest Expense On Debt Change Date
Acasti Pharma USD 0 0 Dec/2024
Addus HomeCare USD 3.52M 493K Jun/2025
Amarin USD 3K 3K Dec/2024
Cassava Sciences 2.6M 301K Sep/2024
Knight Therapeutics CAD 1.91M 369K Sep/2024
Option Care Health USD 14.45M 1.22M Jun/2025
Tilray USD 7.77M 2.08M Nov/2024